These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19446915)

  • 1. What offers the best prediction of sustained virologic response during combination therapy with interferon and ribavirin: viral dynamics, viral levels at certain time points, or a combination of both?
    Weiland O
    J Hepatol; 2009 Jul; 51(1):4-7. PubMed ID: 19446915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of measuring HCV-RNA levels in patients with chronic hepatitis C by IFN treatment, including combination therapy with ribavirin].
    Kakumu S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):507-10. PubMed ID: 15359851
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of patients with chronic hepatitis C virus infection and normal transaminases].
    Serfaty L
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B202-5. PubMed ID: 12180289
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis C: therapeutic perspectives].
    Trépo C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B297-302. PubMed ID: 12180304
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic hepatitis C. A new chance with Consensus Interferon for patients with handicaps].
    MMW Fortschr Med; 2002 Nov; 144(45):56-7. PubMed ID: 12534066
    [No Abstract]   [Full Text] [Related]  

  • 6. Ribavirin posology, observance, and sustained virologic response.
    Couzigou P; Foucher J; Castera L; De Ledinghen V
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):367. PubMed ID: 18063421
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic effects of interferon on chronic hepatitis C from the aspect of dosage and method of administration].
    Fukuda A
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):493-6. PubMed ID: 15359848
    [No Abstract]   [Full Text] [Related]  

  • 8. Approach to the treatment-experienced patient with hepatitis C virus genotype 1 infection.
    Flemming JA; Terrault NA
    Infect Dis Clin North Am; 2012 Dec; 26(4):903-15. PubMed ID: 23083823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualisation of antiviral therapy for chronic hepatitis C.
    Teoh NC; Farrell GC; Chan HL
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1206-16. PubMed ID: 20594246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
    Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
    Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients.
    Santagostino E; De Filippi F; Rumi MG; Rivi M; Colombo M; Mannucci PM;
    Transfusion; 2004 May; 44(5):790-4. PubMed ID: 15104664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
    Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
    Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quality of life of patients with chronic hepatitis C: effect of treatments].
    Couzigou P
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B257-63. PubMed ID: 12180299
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with ronkoleukin and alfaferon combination in complex chronic hepatitis C treatment].
    Popova LL; Suzdal'tsev AA; Konstantinov DIu; Golik OO; Vasil'ev SIu
    Eksp Klin Gastroenterol; 2011; (6):102-7. PubMed ID: 22168088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New triple therapy in chronic hepatitis C. Increased patient chances].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Sep; 153(39):20. PubMed ID: 21991830
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response.
    Halfon P; Khiri H; Tran A; Pénaranda G; Courcambeck J; Joly H; Ouzan D
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1067-71. PubMed ID: 14501613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of chronic hepatitis C in children].
    Bernard O
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B206-9. PubMed ID: 12180290
    [No Abstract]   [Full Text] [Related]  

  • 18. Modeling the dynamics of hepatitis C virus with combined antiviral drug therapy: interferon and ribavirin.
    Banerjee S; Keval R; Gakkhar S
    Math Biosci; 2013 Oct; 245(2):235-48. PubMed ID: 23891586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of combined interferon-ribavirin in the treatment of chronic hepatitis C.
    Muhammad N; Jan MA; Rahman N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):651-3. PubMed ID: 15530272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C.
    Vigani AG; Pavan MH; Tozzo R; Gonçales ES; Lazarini MS; Oliveira AM; Gonçales FL
    Braz J Infect Dis; 2010; 14(2):193-6. PubMed ID: 20563450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.